ERBB2 and neoplasm: CAR engineering of NK cells to express a receptor targeting Her2 enhances the cytotoxic activity of their exosomes, likely through surface presentation of CAR or the delivery of cytotoxic molecules, leading to higher rates of tumor cell death [61,62].